There are 3397 resources available
1021MO - Safety and efficacy of etigilimab (anti-TIGIT) with nivolumab (anti-PD1) in recurrent/advanced solid tumors
Presenter: Meredith Mckean
Session: Mini oral session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Biomarkers in 2023: What, how and when to test?
Presenter: Hans Prenen
Session: Biomarkers in metastatic colorectal cancer: What has changed in the last few years?
Resources:
Slides
Webcast
Targeting proapoptotic pathways: MDM2 and beyond
Presenter: Sebastian Bauer
Session: New mechanisms and drugs for the treatment of patients with sarcomas
Resources:
Slides
Webcast
The importance of harmonizing screening programmes across different levels of healthcare systems: Europe, national, regional
Presenter: Rosa Giuliani
Session: The importance of secondary prevention: Early detection and screening programmes
Resources:
Slides
Webcast
Organ preservation for refractory NMIBC: A surgeon's perspective
Presenter: Joost Boormans
Session: Bladder preservation strategies
Resources:
Slides
Webcast
95MO - Tinengotinib in patients with advanced, fibroblast growth factor receptor (FGFR) inhibitor refractory/relapsed cholangiocarcinoma
Presenter: Meredith Pelster
Session: Mini oral session 1 - Gastrointestinal tumours, upper digestive
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA1 and LBA2
Presenter: Marina Garassino
Session: Presidential 1
Resources:
Slides
Webcast
Radiotherapy in bladder preservation
Presenter: Robert Huddart
Session: Bladder preservation strategies
Resources:
Slides
Webcast
Invited Discussant 1020MO and 1021MO
Presenter: Alessandra Curioni-Fontecedro
Session: Mini oral session - Investigational immunotherapy
Resources:
Slides
Webcast
Biomarkers in the near future: What to expect?
Presenter: Filippo Pietrantonio
Session: Biomarkers in metastatic colorectal cancer: What has changed in the last few years?
Resources:
Slides
Webcast